Covered recipient · General Payments record
LIANET SUAREZ GARCIA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$1,163.87
- Reported across 63 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $560.74 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $225.47 | 15 |
| Novo Nordisk AS | $149.91 | 8 |
| Amgen Inc. | $51.94 | 3 |
| Acerta Pharma LLC | $44.05 | 2 |
| Exact Sciences Corporation | $20.69 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.59 | 1 |
| ABBVIE INC. | $16.21 | 1 |
| IBSA Pharma Inc. | $16.19 | 1 |
| Merck Sharp & Dohme Corporation | $15.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.21 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108269548 | CMS |
| Amgen Inc. | $17.07 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117694891 | CMS |
| Amgen Inc. | $17.72 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117393510 | CMS |
| Amgen Inc. | $17.15 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117694893 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.22 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105895012 | CMS |
| AstraZeneca Pharmaceuticals LP | $25.83 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105377931 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $20.59 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086275128 | CMS |
| Exact Sciences Corporation | $20.69 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114922609 | CMS |
| IBSA Pharma Inc. | $16.19 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142983246 | CMS |
| Lilly USA, LLC | $15.12 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135799120 | CMS |
| Lilly USA, LLC | $18.09 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135797450 | CMS |
| Lilly USA, LLC | $19.21 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135815236 | CMS |
| Lilly USA, LLC | $18.09 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135799122 | CMS |
| Lilly USA, LLC | $15.12 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135752423 | CMS |
| Lilly USA, LLC | $8.73 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135788978 | CMS |
| Lilly USA, LLC | $9.54 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135788980 | CMS |
| Lilly USA, LLC | $15.36 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135764843 | CMS |
| Lilly USA, LLC | $19.05 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135815234 | CMS |
| Lilly USA, LLC | $13.42 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135752425 | CMS |
| Lilly USA, LLC | $13.31 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135752427 | CMS |
| Lilly USA, LLC | $12.09 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135790812 | CMS |
| Lilly USA, LLC | $16.88 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135752429 | CMS |
| Lilly USA, LLC | $14.29 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135740368 | CMS |
| Lilly USA, LLC | $17.17 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135740370 | CMS |
| Merck Sharp & Dohme LLC | $15.69 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141558204 | CMS |
| Novo Nordisk Inc | $16.31 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100595357 | CMS |
| Novo Nordisk Inc | $23.85 | 02/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100536921 | CMS |
| Novo Nordisk Inc | $19.09 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100462130 | CMS |
| Novo Nordisk Inc | $14.49 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100271340 | CMS |
| Novo Nordisk Inc | $21.00 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100383767 | CMS |
| Novo Nordisk Inc | $23.08 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100630427 | CMS |
| Novo Nordisk Inc | $15.45 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100463960 | CMS |
| Novo Nordisk Inc | $16.64 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100414595 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.